Herantis Pharma
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här Herantis Pharma Oyj: Managers' Transactions - Antti Vuolanto
Herantis Pharma Plc
Company release 9 June 2023 at EEST
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Antti Vuolanto
Position: Chief Executive Officer
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 33224/5/8
____________________________________________
Transaction date: 2023-06-09
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: 2023 option rights in Herantis Pharma Plc
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
Transaction details
(1): Volume: 165000 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 165000 Volume weighted average price: 0 EUR
____________________________________________
Further information:
Julie Silber/Gabriela Urquilla
Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19
Email:ir@herantis.com
Certified Advisor: UB Securities Ltd, +358 9 25 380 225
Company website: www.herantis.com
Distribution:
Main media
www.herantis.com
| Datum | 2023-06-09, kl 13:15 |
| Källa | Cision |